Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . Rev Diabet Stud. 2023;6(1). Accessed September 20, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/252